GLP-1 Pipeline Update: May 2026 Quarterly view of the GLP-1 pipeline and anticipated indications Editorial team Maryam Tabatabai, PharmD Editor-In-Chief Associate Vice President, Clinical Information Carole Kerzic, RPh Executive Editor Drug Information Pharmacist Principal Nicole Kjesbo, PharmD, BCPS Executive Editor Clinical Program Development Director Senior, Pipeline DISCLAIMER The drug pipeline is fluid
RoshanravanNMahdaviRAlizadehEJafarabadiMAHedayatiMGhavamiAet alEffect of butyrate and inulin supplementation on glycemic status, lipid profile and glucagon-like peptide 1 level in patients with type 2 diabetes: a randomized double-blind, placebo-controlled trial
The main condition being discussed is non-arteritic anterior ischemic optic neuropathy (NAION) , a rare issue where blood flow to the optic nerve is disrupted, sometimes leading to sudden and even permanent vision loss
When people drop weight quickly, as is often the case with GLP-1s, they are not just shedding fat but also lean body mass, which includes muscle
Common ones include nausea, vomiting, diarrhea, and constipation
How Non-Surgical Tightening Works Most non-surgical skin tightening devices such as radiofrequency, ultrasound, or targeted light to gently heat the deeper layers of the skin while protecting the surface
